Skip to main content
Clinical Trials/CTRI/2012/04/002610
CTRI/2012/04/002610
Completed
Phase 2

Efficacy of autologous platelet rich fibrin (PRF)and Sree Chitra Hydroxy apatite bioactive glass (HABG)in the management of localized intra bony defects -A randomized controlled Trial.

nil0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
nil
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 10, 2012
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
nil

Eligibility Criteria

Inclusion Criteria

  • patients diagnosed with localized chronic moderate or localized agressive periodontitis with clinical attachment loss \>2mm, \<5mm.

Exclusion Criteria

  • systemic or infectious diseases,insufficient platelet count for PRF preparation,intake of any mediations that will interfere with bloood clotting

Outcomes

Primary Outcomes

Not specified

Similar Trials